Results 191 to 200 of about 32,846 (250)

Analysis of Obesity Care in Spanish Healthcare Settings: OBEQUIDAD Study

open access: yesObesity Science &Practice, Volume 12, Issue 2, April 2026.
ABSTRACT Background Obesity management remains influenced by misconceptions about the disease, which compromise care quality. Introduction The OBEQUIDAD study explores the clinical management of people with obesity in Spain based on the perspectives of healthcare professionals involved in its treatment across different medical specialties.
Ana de Hollanda   +7 more
wiley   +1 more source

Optimizing Obesity Management With GLP‐1 Agonist Medication Through Mobile Health Technology, Nutrition Therapy, and Progressive Strength Training: A Retrospective Program Review

open access: yesObesity Science &Practice, Volume 12, Issue 2, April 2026.
ABSTRACT Background GLP‐1 RAs are effective in treating obesity; however, they typically result in significant loss of skeletal muscle mass. Real‐world evidence to inform systematic guidelines and clinical implementation for preserving skeletal muscle mass and reducing cardiometabolic risk with lifestyle modifications on GLP‐1 RAs remains limited ...
Elizabeth Sharp Edens   +3 more
wiley   +1 more source

GLP-1 receptor agonists for weight loss: A systematic review and meta-analysis of randomized controlled trials. [PDF]

open access: yesMedicine (Baltimore)
Ahmad N   +6 more
europepmc   +1 more source

Targeting Multiple Gut‐Brain Pathways in Obesity: Rationale for Combination Pharmacotherapy

open access: yesObesity Science &Practice, Volume 12, Issue 2, April 2026.
ABSTRACT Background As a disease of energy dysregulation, obesity involves metabolic, hormonal, and neural factors, the interconnection of which is referred to as the “gut‐brain axis.” Objective This review aimed to provide an overview of the clinical evidence of physiological and objective or subjective changes in eating behavior with gut hormone ...
Alexander D. Miras, Muzamil Hussain
wiley   +1 more source

The Effects of SGLT2 Inhibitors on Muscle Health in Older Adults: A Systematic Review and Meta‐Analysis

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 2, April 2026.
SGLT2 inhibitors reduce skeletal muscle mass modestly in older adults with type 2 diabetes. Forest plot (a) and count our funnel plot (b) show a small but significant pooled reduction in muscle mass (SMD = −0.36, 95% CI [−0.56, −0.15]; I2 = 24.1%), with weight loss occurring predominantly through fat mass reduction.
Weena Joongpan   +5 more
wiley   +1 more source

GLP‐1 Receptor Agonists Versus Bariatric Surgery: Effects of Weight Loss and BMI on Subsequent General Surgical Procedures

open access: yesClinical Obesity, Volume 16, Issue 2, April 2026.
ABSTRACT Obesity and T2DM substantially increase postoperative risk, with higher surgical site infections in obesity and up to a 65% increase in overall complications in T2DM. This study assesses the impact of weight loss interventions—metabolic bariatric surgery (MBS) and glucagon‐like peptide‐1 receptor agonists (GLP‐1RA)—on BMI reduction and how ...
Shahzaib Zindani   +10 more
wiley   +1 more source

Liraglutide Ameliorates Injury-Related Vascular Repair by Activating Autophagy Through Modulation of the PI3K-mTOR Signaling Pathway. [PDF]

open access: yesFASEB J
Zhang Z   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy